1.20
                                            Schlusskurs vom Vortag:
              $1.26
            Offen:
              $1.26
            24-Stunden-Volumen:
                10.28M
            Relative Volume:
              1.30
            Marktkapitalisierung:
                $765.62M
            Einnahmen:
              $29.48M
            Nettoeinkommen (Verlust:
              $-201.19M
            KGV:
              -3.75
            EPS:
                -0.32
            Netto-Cashflow:
                $-216.50M
            1W Leistung:
              -6.25%
            1M Leistung:
              -11.11%
            6M Leistung:
                -13.04%
            1J Leistung:
              -70.80%
            Geron Corp Stock (GERN) Company Profile
Firmenname
                  
                      Geron Corp
                    
                Sektor
                  Branche
                  Telefon
                  
                      (650) 473-7700
                    
                Adresse
                  
                      919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
                    
                Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                GERN
                            
                             
                        Geron Corp 
                           | 
                    1.20 | 803.90M | 29.48M | -201.19M | -216.50M | -0.32 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Sell | 
| 2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform | 
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral | 
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy | 
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform | 
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform | 
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral | 
| 2024-04-29 | Eingeleitet | TD Cowen | Buy | 
| 2024-03-15 | Bestätigt | Needham | Buy | 
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy | 
| 2023-03-28 | Eingeleitet | Goldman | Neutral | 
| 2022-10-28 | Eingeleitet | Wedbush | Outperform | 
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy | 
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform | 
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy | 
| 2020-08-03 | Eingeleitet | Stifel | Buy | 
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy | 
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy | 
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2019-04-09 | Hochstufung | Needham | Hold → Buy | 
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy | 
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral | 
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy | 
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform | 
| 2016-09-13 | Bestätigt | FBR Capital | Outperform | 
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight | 
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform | 
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy | 
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold | 
| 2013-12-10 | Bestätigt | MLV & Co | Buy | 
| 2013-12-10 | Hochstufung | Needham | Hold → Buy | 
| 2013-11-08 | Bestätigt | MLV & Co | Buy | 
| 2013-10-16 | Eingeleitet | MLV & Co | Buy | 
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy | 
| 2012-06-28 | Eingeleitet | Needham | Hold | 
                    Alle ansehen
                    
                  
                Geron Corp Aktie (GERN) Neueste Nachrichten
Why Geron Corporation (GON) stock attracts HNW investors2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com
Why analysts maintain buy rating on Geron Corporation (GON) stockEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
Geron (NASDAQ: GERN) announces 5 RYTELO studies at ASH, IMerge oral and MF biomarkers - Stock Titan
Will earnings trigger a reversal in Geron CorporationJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Can Geron Corporation stock sustain free cash flow growth2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com
Geron (NASDAQ:GERN) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
What analyst consensus says on Geron Corporation stockJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Can Geron Corporation (GON) stock attract analyst upgradesQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
What consensus target says about Geron Corporation (GON) stockQuarterly Earnings Summary & Smart Swing Trading Techniques - newser.com
What earnings revisions data tells us about Geron Corporation2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com
Is Geron Corporation stock attractive for ETFs2025 Macro Impact & Consistent Income Trade Ideas - newser.com
What hedge fund activity signals for Geron Corporation stockTrade Volume Report & Fast Momentum Stock Entry Tips - newser.com
Will Geron Corporation stock deliver shareholder valueWeekly Volume Report & AI Driven Price Predictions - newser.com
Geron (GERN) to Release Earnings on Wednesday - MarketBeat
Is Geron Corporation stock cheap at current valuationMarket Movement Recap & Long-Term Investment Growth Plans - newser.com
Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Is Geron Corporation stock a good choice for value investorsMarket Performance Summary & Fast Exit and Entry Strategy Plans - newser.com
Geron (Nasdaq: GERN) sets Nov 5 Q3 results release, webcast planned before market open - Stock Titan
Is Geron Corporation (GON) stock ideal for retirement investorsQuarterly Portfolio Summary & Trade Opportunity Analysis - newser.com
How strong is Geron Corporation (GON) stock earnings growthWeekly Risk Summary & Weekly Market Pulse Alerts - newser.com
Is Geron Corporation (GON) stock a safe buy pre earningsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Geron Corporation (NASDAQ:GERN) Given Average Rating of "Hold" by Analysts - MarketBeat
Cassava (NASDAQ: SAVA) appoints Dawn C. Bir to board; simufilam TSC study in 2026 - Stock Titan
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan
Backtesting results for Geron Corporation trading strategiesJuly 2025 Action & Weekly High Potential Alerts - newser.com
What MACD trends signal for Geron Corporation (GON) stockEarnings Miss & Long-Term Growth Stock Strategies - newser.com
Will Geron Corporation stock gain from strong economyMarket Sentiment Review & Accurate Intraday Trade Tips - Trung tâm Dự báo KTTV quốc gia
Why Geron Corporation (GON) stock gets analyst attentionWeekly Loss Report & Daily Profit Focused Screening - Trung tâm Dự báo KTTV quốc gia
When is the best time to exit Geron CorporationWeekly Profit Report & Technical Buy Zone Confirmations - newser.com
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):